Caroline Ford (medical researcher)

Caroline Ford is an Australian medical researcher specializing in liver disease, particularly hepatocellular carcinoma (HCC), the most common type of liver cancer. Her research focuses on understanding the molecular mechanisms driving HCC development and progression, with the goal of identifying new therapeutic targets and improving patient outcomes.

Ford obtained her PhD in molecular biology and has held research positions at leading institutions, including the Centenary Institute and the Garvan Institute of Medical Research in Sydney, Australia. She currently leads a research group investigating the role of specific genes and signaling pathways in HCC, and is involved in translational research aimed at bringing laboratory discoveries to clinical trials. Her work encompasses areas like non-alcoholic steatohepatitis (NASH)-related HCC, the tumor microenvironment, and immunotherapy for liver cancer. Ford is a recognized expert in the field and frequently publishes her findings in peer-reviewed scientific journals and presents at international conferences. She actively collaborates with other researchers and clinicians both nationally and internationally.